Baddi: USV, an Indian multinational healthcare company, has announced the opening of a dedicated new manufacturing plant in Baddi, Himachal Pradesh.
"The new dedicated facility will improve access to high quality and affordable Ecosprin AV and further strengthen its leadership in the cardiology segment. With this new facility, the product will now be available in a more patient friendly pack," USV said in a release.

There are an increasing number of cases of cardiac events in our country even for younger individuals. Aspirin and Atorvastatin play a vital role in heart health to protect patients from cardiac events.
The plant was inaugurated by Mr Debabrata Bhadury, Director, USV in the presence of USV Chairperson Ms. Leena Gandhi Tewari and Managing Director Mr Prashant Tewari.
“This modern facility is of strategic importance to serve Indians to keep their heart healthy by offering a lifesaving quality brand at an affordable price”, said Leena Gandhi Tewari at the plant inauguration.
Mr Prashant Tewari, Managing Director said “This new unit at Baddi will contribute further to our responsibility of saving lives through offering quality medicines.”
The plant uses high-tech machinery and advanced technology in manufacturing and automated process checks to assure product quality and efficacy. The plant has many green initiatives like renewable energy usage, rainwater harvesting, and tree plantation already incorporated, right from inception.
M M Venkatachalam, Director USV said “The facility is very impressive and upgraded in terms of technology used, automation, QC, testing and sustainability practice. In the recent past USV has made great strides in new facilities, technologies, efficiencies, and capacities.”
Established in 1961, USV Private Limited is a Indian multinational healthcare companies with a presence in 65+ countries, with its products. USV’s global product offerings include Active Pharmaceutical Ingredients (APIs), generics, branded generics, Peptides, and Biosimilars.
Read also: USV Launches INSUQUICK, First Biosimilar Insulin Aspart in India